Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
Company

Yposkesi


26, rue Henri-Desbruères
91100 CORBEIL-ESSONNES – FRANCE
Phone: +33 1 61 61 70 01
Email: alamproye@yposkesi.com

Frédéric REVAH: President
Site Web >
Yposkesi - Genopole's Company Yposkesi - Genopole's Company

#Biomanufacturing / Pharmaceutical Services #Industrial Biotech

  • Rare diseases
  • Gene therapy
  • Cell therapy
  • Tissue replacement
  • GMPs
  • Contract Manufacturing

Field of Activity


Yposkesi is the first French company to develop and manufacture gene and cell therapy products for rare diseases.

BACKGROUND

Created in November 2016 by AFM-Telethon and the SPI fund managed by Bpifrance, this new company aims to make gene and cell therapies available to patients at a fair and controlled price, in accordance with the commitment made by its founders.

DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY

Activities:

  • Contract and development manufacturing organization (CDMO)
  • Contract manufacturing organization for gene and cell therapy products (pre-clinical and clinical batches).
  • Innovation and development of process and analytical technologies in the field of gene and cell therapy.

CUSTOMER REFERENCES /COLLABORATIONS / HIGHLIGHTS

Yposkesi is certified as a pharmaceutical establishment (medicinal product for humanuse) by ANSM, the French national agency for health product safety.
The strategy of Yposkesi is focused on extending production capacities through planned investments.

  • 1 large scale manufacturing unit for viral vectors (commercial), planned for 2021.
  • 1 R&D unit (process & analytical development) planned for 2018.
  • Modular cleanroom facilities for the GMP manufacturing of cell therapy products planned for 2021.
  • Further information

    145 Staff members

    Strengths
    – Biggest European Project for the production of gene and cell therapies.
    – Broad epertise in the production process developmentand the associated control methods.

    Innovation Assets
    10% of Yposkesi human resources dedicated to innovation and development of new technologies.

Share
Genopole’s Companies

#Biomanufacturing / Pharmaceutical Services


In same field

Proteinea - Genopole's company

Proteinea

Production as a service (PaaS) platform capable of producing recombinant proteins & enzymes cheaper and on a scale.

Discover
Altar - entreprise génopolitaine

Altar

Altar is a specialist in the conception and operation of automated fluidic continuous culture systems for adaptive laboratory evolution and the development of microbial strains for industry.

Discover
Yubsis - Genopole's company

Yubsis

Yubsis provides Biological Science Information Solutions. Our platform is designed for research organizations willing to improve real-time teamwork, optimize performance and accelerate innovation

Discover
Watchfrog Laboratory - Genopole's company

WatchFrog

WatchFrog markets in vivo biotechnological solutions for environmental risk assessment and the evaluation of the therapeutic, toxic or pollutant potential of all types of chemical, cosmetic or pharmaceutical compounds.

Discover
Texcell - Genopole's Company

Texcell

Texcell offers fully GLP- and GMP-compliant viral safety testing and immunomonitoring services.

Discover
Pymabs - Genopole's Company

Pymabs

R & D services in the field of transient expression of recombinant proteins in plants.

Discover
Hybrigenics - Genopole's company

Hybrigenics Services

Hybrigenics Services offers high-quality services to i) discover novel protein interactions, ii) identify the targets of drug candidates and iii) select novel, synthetic single-domain antibodies against any antigen (nanobodies).

Discover
Genosafe - Genopole's Company

Genosafe

GenoSafe is a full contract research and consulting organization specialized in evaluating the quality, safety and efficacy of innovative biological products. Our goal is to enable our clients to move their products along clinical development rapidly and efficiently.

Discover
Eukarÿs - Genopole's company

Eukarÿs

Synthetic gene therapy for the treatment of severe human liver diseases and tools for the bioproduction of recombinant proteins and viruses using the proprietary expression system C3P3.

Discover
ABOLIS - entreprise génopolitaine

Abolis Biotechnologies

Development of custom-order microorganisms able to produce molecules of interest in health, nutrition, cosmetics, chemistry and agriculture.

Discover
View all >
With support